Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
MRI-Guided Reduced-Volume RT for Early-Stage Glottic Cancer: A Prospective Phase 1 Trial with Quantification of Laryngeal Motion.
Journal: International journal of radiation oncology, biology, physics
Published: May 10, 2026
Response to Wang et al., "Time as a Substantial Confounder in Evaluating Integrated Multidisciplinary Care for Advanced Cutaneous Squamous Cell Carcinoma".
Journal: Journal of the American Academy of Dermatology
Published: May 10, 2026
Discordant circulating tumor DNA results favor multiple primary malignancies in patient with synchronous Merkel cell carcinoma tumors.
Journal: JAAD case reports
Published: February 13, 2026
Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial.
Journal: Nature communications
Published: January 29, 2026
Lenalidomide for the Treatment of Chronic Oral Mucositis and Soft Tissue Necrosis After Radiation Therapy.
Journal: Practical radiation oncology
Published: January 12, 2026
Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 23, 2025
Integrated multidisciplinary care reduces time to treatment in patients with advanced cutaneous squamous cell carcinoma: A retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: December 11, 2025
Progression patterns and clinical outcomes in patients with cutaneous squamous-cell carcinoma following anti-PD-1 therapy failure.
Journal: ESMO open
Published: August 30, 2025
Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Early Glottic Cancer: A Review.
Journal: JAMA otolaryngology-- head & neck surgery
Published: August 28, 2025
Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial.
Journal: International journal of radiation oncology, biology, physics
Published: July 01, 2025
Circulating Tumor DNA Predicts Response After Definitive Radiation Therapy for Merkel Cell Carcinoma.
Journal: Advances in radiation oncology
Published: June 02, 2025
Last Updated: 09/26/2026